Genmab A/S 2021 SR
The report highlights Genmab's 2021 progress in its journey to become a fully integrated biotech innovation powerhouse, marked by the approval of its first medicine, Tivdak. The company advanced its Corporate Social Responsibility (CSR) strategy by committing to the Task Force on Climate-related Financial Disclosures (TCFD) and the Science Based Targets initiative (SBTi). Key achievements include maintaining a workforce with 58% female representation and 51% women in leadership roles at the director level and above. Genmab also focused on employee well-being, community support through the Community@Genmab portal, and environmental sustainability by calculating its initial Scope 1 and 2 carbon footprint.
Company: Genmab A/S
Sector: Professional & technical services
Country: Denmark
Year: 2021
Type: SR
Pages: 39
Back to company
Genmab A/S
Corporate Responsibility Report
The report highlights Genmab's 2021 progress in its journey to become a fully integrated biotech innovation powerhouse, marked by the approval of its first medicine, Tivdak. The company advanced its Corporate Social Responsibility (CSR) strategy by committing to the Task Force on Climate-related Financial Disclosures (TCFD) and the Science Based Targets initiative (SBTi). Key achievements include maintaining a workforce with 58% female representation and 51% women in leadership roles at the director level and above. Genmab also focused on employee well-being, community support through the Community@Genmab portal, and environmental sustainability by calculating its initial Scope 1 and 2 carbon footprint.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees